The table below shows Viking Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$0.00
$0.00
$0.00
$0.00
$0.00
$0.00
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$150.15M
$89.95M
$60.15M
$41.39M
$22.79M
$23.77M
SG&A
VKTX annual revenue (10-K history)
Viking Therapeutics, Inc. reported annual revenue of $0.00 for fiscal year 2025. Figures come from the company's audited annual reports as filed with the SEC.
